Infections in Systemic Autoimmune Diseases

Risk Factors and Management

Häftad, Engelska, 2020

Del 16 i serien Handbook of Systemic Autoimmune Diseases

1 791 kr

Beställningsvara. Skickas inom 7-10 vardagar. Fri frakt över 249 kr.

Beskrivning

Infections in Systemic Autoimmune Diseases: Risk Factors and Management, Volume Sixteen describes the state-of-the-art of the risk factors and management treating the most common systemic autoimmune diseases (SADS). This updated volume consists of an introductory chapter that provides a brief overview of what different types of infectious diseases exist, followed by eight chapters detailing risk factors, guidelines and recommendations per different disease and bacterial infections. International in scope, the list of more than 20 contributors from Europa and America reads like a who's who of clinical researchers in the field.

Written by leading international clinical/surgical and scientific experts on Infection problems in systemic autoimmune diseases
Provides a practical guide to the safer treatment of infections in patients with autoimmune diseases
Includes a number of problems and recommendation that cannot be found in other books
Designed as a 'guide to clinical practice' for management and risk interventions required by patients with SAD's

Produktinformation

Utgivningsdatum:2020-03-10
Mått:152 x 229 x 18 mm
Vikt:430 g
Format:Häftad
Språk:Engelska
Serie:Handbook of Systemic Autoimmune Diseases
Antal sidor:228
Förlag:Elsevier Science
ISBN:9780444642172

Utforska kategorier

Onkologi inom Medicin

Mer om författaren

Fabiola Atzeni, MD, PhD is currently Full Professor and Head of the Rheumatology Unit, University of Messina, Messina, Italy. Her clinical and research interest lies in immunotherapies in autoimmune diseases with particular focus on the investigation and management of differential response to biological therapies in rheumatoid arthritis (RA) and Spondyloarthritis (SpA), and cardiovascular aspects of the different rheumatic diseases with particular emphasis on arteriosclerosis. Dr. Atzeni has co-authored over 400 publications in peer-reviewed journals and several book chapters, is a regular reviewer for several international journals. She is involved in several international and national meetings focused on cardiovascular and infection aspects. Massimo is Doctor of medicine at the University of Milan. And director of the department ofinfectious diseases Professor Juan Jose Gomez Reino MD is head of the rheumatology department at the University of Santiago. Juan obtained his MD and PhD from the Autonomous University of Madrid, he undertook his post doc training at the New York State University , Stony Brook USA. His clinical research mainly focuses on the search for improved treatments for Rheumatoid Arthrosis and Atherosclerosis which has resulted in many clinical treatment solutions. Dr Galloway is a clinical lecturer at King's College London and an honorary consultant in rheumatology at King's College Hospital. He runs the biologics assessment service for the rheumatology department. His research background has been in the study of biologic therapy safety. Within his role for KCL he works in the CRC accredited King's Clinical Trials Unit which has a large portfolio of investigator led trials. He also runs a phase 1 clinic in collaboration with the BRC facility and the Quintiles MHRA accredited Early Phase clinical trials unit at Guy's Hospital.

Recensioner i media

"This is a short yet comprehensive book describing infections in systemic autoimmune diseases. This series, with over 30 contributors and 15 predecessor volumes to this 16th volume, collectively presents a comprehensive resource forrheumatologists, clinical immunologists, infectious disease specialists, and internists who are searching for updates on the subject." --Doody

Innehållsförteckning

1. The spectrum of infectious disease2. Comorbidities in patients with rheumatic disease3. Drugs used in rheumatic disease4. Risk/benefit management in the infectious phase5. Vaccine recommendations in patients with systemic rheumatic diseases6. Education for patients/family and doctors